. 2018 Oct 25;32(6):1927–1933. doi: 10.1111/jvim.15327

Table 1.

Hematocrit, platelet count, buccal mucosal bleeding time (BMBT), prothrombin time (PT), activated partial thromboplastin time (aPTT). Data represent the mean ± SD of 6 dogs that did not undergo acute hemorrhage followed by volume replacement (VR) in one occasion (control treatment) or that underwent hemorrhage and randomly received VR with lactated Ringer's solution (LRS treatment) or with 6% tetrastarch solution (TS treatment) at a ratio of 3:1 or 1:1 the volume of shed blood, respectively. Variables were recorded during anesthesia, before hemorrhage (BL), 0.5, 2, and 4 hours after VR. Anesthesia was interrupted 4 hours after VR, and data were collected 24 hours after VR

Variable	Reference range	Treatment		Time after VR, hours
Variable	Reference range	Treatment	BL	0.5	2	4	24
Hematocrit, %	38‐48	Control	43 ± 3	41 ± 4^a	40 ± 2^a	40 ± 2^a	45 ± 3^a
		LRS	41 ± 2	32 ± 2^b	34 ± 2^b	37 ± 3^b	36 ± 3^b
		TS	42 ± 3	32 ± 4^b	35 ± 2^b	36 ± 1^b	39 ± 3^c
Platelet count, ×10³/μL	200‐500	Control	332 ± 44	346 ± 67^a	327 ± 36^a	317 ± 48^a	314 ± 43^a
		LRS	323 ± 57	213 ± 47^b	262 ± 61^b	252 ± 67^b	242 ± 35^b
		TS	302 ± 42	232 ± 28^b	291 ± 54^ab	294 ± 40^ab	268 ± 16^b
BMBT, second	<240	Control	61 ± 16^ab	63 ± 15	57 ± 14	56 ± 12	97 ± 40
		LRS	86 ± 22^a	56 ± 14	60 ± 19	52 ± 15	80 ± 38
		TS	50 ± 16^b	74 ± 21	79 ± 35	51 ± 21	76 ± 39
PT, second	11‐17	Control	15 ± 1	15 ± 1^a	17 ± 3	15 ± 2	13 ± 1
		LRS	14 ± 1	16 ± 2^a	15 ± 1	15 ± 1	13 ± 1
		TS	14 ± 1	13 ± 1^b	16 ± 1	14 ± 1	13 ± 1
aPTT, second	72‐102	Control	72 ± 9	73 ± 9	75 ± 14	73 ± 9^a	80 ± 11
		LRS	75 ± 12	92 ± 29	82 ± 15	83 ± 9^ab	87 ± 6
		TS	79 ± 15	89 ± 24	90 ± 14	91 ± 16^b	79 ± 10

Within each column. For a given time point, treatment group means followed by different superscript letters are significantly different from each other (Tukey's test, P ≤ 0.05).